Parmax Pharma Ltd.BSE: PARMAX

Parmax Pharma Ltd. Press Release Feb 14 2025

· Moneycontrol

In accordance with amendments to the SEBI (LODR) Regulations, 2024 read with SEBI circular No. SEBI/HO/CFD-PoD2/CIR/P/2024/185 dated 31st December, 2024 read with BSE circular no. 20250102-4 dated 2nd January, 2025, the integrated filing of financial statements for the quarter ended on 31st December, 2024 is attached herewith.

View Attachment